Group 1 - The National Healthcare Security Administration has released a new directory of innovative drugs for medical insurance, with negotiations starting on November 4. If new products are included in the insurance directory, it will be a positive development; otherwise, related companies may face short-term negative impacts [1] - A new 2MWT liquid fuel thorium-based molten salt experimental reactor has been established by the Shanghai Institute of Applied Physics, indicating progress in the nuclear power sector and potential upward reversal expectations for related fields [1] Group 2 - The A-share market is expected to experience a short-term pullback, but a rebound is anticipated in the early part of the week. Recent market conditions show divergence in major indices and commodity prices, with slight depreciation of the RMB, which may exert short-term pressure on the market [1] - Technical analysis indicates that the three major indices have faced upward pressure, with a significant drop in trading volume during the market's pullback, suggesting a decrease in short-selling intentions. The market is close to a key support level at 3936 points, which, if not breached, could lead to a reversal [2] - Investors are advised to be cautious with high-flying technology stocks during market pullbacks, while being patient with lower-performing technology and financial stocks. As long as key support levels are maintained, investors can wait for potential rebounds [2]